Sponsored by:

Nuclear Medicine: Page 220

C-11 PiB PET shows treatment success for Alzheimer's disease
By Wayne Forrest
Using PET imaging with the radiopharmaceutical carbon-11-labeled Pittsburgh Compound B (C-11 PiB), researchers found that treatment with the antibody gantenerumab appeared to reduce amyloid levels in the brains of Alzheimer's patients, according to a report published online October 10 in Archives of Neurology.
October 9, 2011
PETNet teams with UC Davis, NCPIC
By AuntMinnie.com staff writers
Siemens Healthcare subsidiary PETNet Solutions has formed a partnership with the University of California (UC) Davis Health System and Northern California PET Imaging Center (NCPIC).
October 9, 2011
New PET agent sees early tumors
By AuntMinnie.com staff writers
Researchers from Vanderbilt University have developed PET imaging agents that could make it possible to visualize tumors in their earliest stages before they become deadly, according to a study in the October issue of Cancer Prevention Research.
October 9, 2011
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
October 9, 2011
AECL's NRU closer to license renewal
By AuntMinnie.com staff writers
The Canadian Nuclear Safety Commission this week received a recommendation that Atomic Energy of Canada (AECL) be granted an operating permit for its National Research Universal (NRU) reactor for the next five years.
October 6, 2011
SNM restarts development initiative
By AuntMinnie.com staff writers
The Society of Nuclear Medicine Technologist Section (SNMTS) has relaunched its Professional Development and Education Fund to support the advancement of molecular and nuclear medicine technologists through clinical excellence and optimal patient outcomes.
October 6, 2011
FDA hits Columbia with warning letter over radiopharma drugs
By Wayne Forrest
The U.S. Food and Drug Administration has issued a warning letter to Columbia University Medical Center in New York City for allegedly failing to comply with FDA regulations on the use of radioactive drugs for human research.
October 5, 2011
ASTRO: FDG-PET aids prognosis for NSCLC
By AuntMinnie.com staff writers
Post-treatment FDG-PET scans may be able to predict the prognosis of patients with stage II and III inoperable non-small cell lung cancer (NSCLC), according to a study presented on October 5 at the American Society for Radiation Oncology (ASTRO) annual meeting in Miami Beach, FL.
October 5, 2011
Fla. university nets $5M nuclear physics grant
By AuntMinnie.com staff writers
Florida State University has received a three-year, $5 million grant from the U.S. National Science Foundation for ongoing research in nuclear physics.
October 3, 2011
Virtual bronchoscopy helps NSCLC patients
By AuntMinnie.com staff writers
German researchers have developed a virtual fly-through 3D FDG-PET/CT bronchoscopy technique that achieves high diagnostic accuracy for detecting regional lymph node metastases in patients with non-small cell lung cancer (NSCLC), according to a study in the October issue of the Journal of Nuclear Medicine.
October 3, 2011
Lantheus promotes 2 executives
By AuntMinnie.com staff writers
Lantheus Medical Imaging has promoted Cyrille Villeneuve to chief commercial officer and Dr. Dana Washburn to chief medical officer.
September 28, 2011
Siemens advances with PET biomarker
By AuntMinnie.com staff writers
Siemens Healthcare announced that it has recently completed a phase II multicenter clinical trial for its HX4 PET imaging biomarker.
September 27, 2011
Previous Page
Page 220 of 440
Next Page